...
机译:自由基肾脏表切除术治疗患有大型尿路上皮癌(UTUC)患者的全身炎症改性Glasgow预后评分的预后价值:大型多中心国际合作的结果
Torino Sch Med Dept Surg Sci Div Urol Turin Italy;
Torino Sch Med Dept Surg Sci Div Urol Turin Italy;
Med Univ Vienna Dept Urol Vienna Austria;
Med Univ Vienna Dept Urol Vienna Austria;
Sorbonne Univ Hop Pitie Salpetriere AP HP GRC 5 ONCOTYPE URO Paris France;
Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;
Univ Montreal Dept Urol Montreal PQ Canada;
Univ Vita Salute San Raffaele San Raffaele Sci Inst Urol Res Inst Dept Urol Milan Italy;
Univ Rennes Dept Urol Rennes France;
Univ Rennes Dept Urol Rennes France;
Jagiellonian Univ Dept Urol Krakow Poland;
Charles Univ Prague Fac Med 2 Dept Urol Prague Czech Republic;
IM Sechenov First Moscow State Med Univ Inst Urol &
Reprod Hlth Moscow Russia;
IM Sechenov First Moscow State Med Univ Inst Urol &
Reprod Hlth Moscow Russia;
Med Univ Vienna Dept Urol Vienna Austria;
Med Univ Vienna Dept Urol Vienna Austria;
Torino Sch Med Dept Surg Sci Div Urol Turin Italy;
Med Univ Vienna Dept Urol Vienna Austria;
Upper tract urothelial carcinoma; UTUC; Glasgow prognostic score; Prediction; Prognosis;
机译:自由基肾脏表切除术治疗患有大型尿路上皮癌(UTUC)患者的全身炎症改性Glasgow预后评分的预后价值:大型多中心国际合作的结果
机译:采用自由基肾病术治疗尿路尿路上皮癌患者术前白蛋白 - 球蛋白比例的预后价值:大型多中心国际合作的结果
机译:自由基肾上腺位落切除术治疗患者白蛋白/球蛋白比例的预后价值
机译:基于系统炎症的格拉斯哥预后评分是上尿路尿路上皮癌患者的有力预后因素
机译:术前淋巴细胞相关全身炎性生物标志物在激进的脑梗塞术治疗术前尿路上皮癌患者的预后价值:系统综述与荟萃分析